4Basebio

4Basebio company information, Employees & Contact Information

Explore related pages

Related company profiles:

4basebio is enabling next generation cell and gene therapies and vaccines with it's technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads. Our novel synthetic DNA technology offers unique customisation potential, rapid turn-around times, and improved safety profiles, addressing the current limitations of plasmids and other DNA technologies. We currently offer four DNA construct types, each ideally suited for use in viral and non-viral vector applications, genome editing, vaccines and therapeutics, and DNA vaccine applications, respectively. Our proprietary non-viral delivery system, Hermes™, is a nanoparticle vector that can be customised to target cells or tissues of interest for a range of applications. This combines the safety and efficiency of lipid-based nanoparticles (LNPs) with the specificity of a targeting system, addressing the shortcoming associated with both viral vectors and non-targeted LNPs.

Company Details

Employees
130
Address
25 Norman Way, Over,united Kingdom
Industry
Biotechnology
Keywords
Technician jobs.
HQ
Cambridge
Looking for a particular 4Basebio employee's phone or email?

4basebio Questions

News

4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies - Business Wire

4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies Business Wire

4basebio receives MHRA licence for synthetic DNA manufacture - PharmaTimes

4basebio receives MHRA licence for synthetic DNA manufacture PharmaTimes

4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA - News-Medical

4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA News-Medical

4basebio appoints Gabe Longoria as Chief Commercial Officer - Cambridge Network

4basebio appoints Gabe Longoria as Chief Commercial Officer Cambridge Network

4basebio CEO Increases Stake in Company - TipRanks

4basebio CEO Increases Stake in Company TipRanks

4basebio Appoints Chief Commercial Officer - Contract Pharma

4basebio Appoints Chief Commercial Officer Contract Pharma

UK: 4basebio announces £40m equity issuance and £29.4m secondary sale - Investors in Healthcare

UK: 4basebio announces £40m equity issuance and £29.4m secondary sale Investors in Healthcare

4basebio PLC : Quotes, Address, Contact - News-Medical

4basebio PLC : Quotes, Address, Contact News-Medical

4basebio partner starts dosing patients in opDNA-based trial - Sharecast.com

4basebio partner starts dosing patients in opDNA-based trial Sharecast.com

4basebio raises £40m growth capital - Business Weekly

4basebio raises £40m growth capital Business Weekly

Hill Dickinson advises 4basebio PLC on £40 million equity issuance and £29.4 million secondary sale - Hill Dickinson

Hill Dickinson advises 4basebio PLC on £40 million equity issuance and £29.4 million secondary sale Hill Dickinson

Top 4Basebio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant